-
First Patient Dosed in Trial Testing Safety, Efficacy of SAR442168 in RRMS
The first patient was dosed in a clinical trial evaluating the safety, efficacy, and tolerability of SAR442168 therapy candidate in relapsing MS patients. Read more about the trial here.
Are you optimistic about this RRMS therapy?
Sorry, there were no replies found.
Log in to reply.